Mevia

Mevia is a health care startup founded in 2014 with its headquarters in Sweden. The company aims to tackle the issue of medication non-adherence through innovative and personalized solutions. Mevia offers intelligent tools to enhance the quality of medical treatments by focusing on improving patient adherence in real-time. The company works closely with clients to develop custom packaging and IT solutions to provide patients with a superior treatment experience. Their recent venture round secured a significant investment of kr3.00M on 01 March 2023 with Chalmers Ventures as the primary investor, highlighting investor confidence in Mevia's potential to address a critical healthcare challenge. The company's slogan, "A leading partner in solving the problem of medication non-adherence through reliable and customized solutions," encapsulates their core mission and market positioning.